Evidence map›Paper›PMID 40889027›Full record

ArticleEJNMMI research2025

Yttrium-90 selective internal radiation therapy for right hepatic malignancies: a clinical outcome study.

Xin Huang, Yong Liao, Ziwei Liang, Junpeng Ma, Bin Liang, Shizhong Yang, Guangxin Li, Tiantian Zhang, Linxia Zheng, Yafei Zhang and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Advanced healthcare materials · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Xin Huang *Department of Hepatobiliary and Pancreatic Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, 102200, P. R. China.
Yong Liao *Department of Hepatobiliary and Pancreatic Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, 102200, P. R. China.
Ziwei Liang *Yttrium-90 Precision Interventional Radiotherapy Center, School of Clinical Medicine, Tsinghua Medicine, Tsinghua Changgung Hospital, Tsinghua University, Beijing, 102200, P. R. China.
Junpeng MaDepartment of Hepatobiliary and Pancreatic Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, 102200, P. R. China.
Bin LiangYttrium-90 Precision Interventional Radiotherapy Center, School of Clinical Medicine, Tsinghua Medicine, Tsinghua Changgung Hospital, Tsinghua University, Beijing, 102200, P. R. China.
Shizhong YangDepartment of Hepatobiliary and Pancreatic Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, 102200, P. R. China.
Guangxin LiDepartment of Radiotherapy, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, 102200, P. R. China.
Tiantian ZhangYttrium-90 Precision Interventional Radiotherapy Center, School of Clinical Medicine, Tsinghua Medicine, Tsinghua Changgung Hospital, Tsinghua University, Beijing, 102200, P. R. China.
Linxia ZhengDepartment of Hepatobiliary and Pancreatic Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, 102200, P. R. China.
Yafei ZhangDepartment of Hepatobiliary and Pancreatic Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, 102200, P. R. China.
Mulan TangDepartment of Hepatobiliary Intervention, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, 102200, P. R. China.
Bo JiaDepartment of Hepatobiliary and Pancreatic Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, 102200, P. R. China.
Lin ZhangDepartment of Hepatobiliary and Pancreatic Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, 102200, P. R. China. 2834018037@qq.com.
Xiaobin FengDepartment of Hepatobiliary and Pancreatic Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, 102200, P. R. China. fengxiaobin@mail.tsinghua.edu.cn.ORCID http://orcid.org/0000-0002-3580-4696

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSurgical resection offers long-term survival for liver malignancies, but insufficient future liver remnant (FLR) volume often precludes operability. This study evaluated yttrium-90 selective internal radiation therapy (

resultsThirty-seven patients (29 hepatocellular carcinomas, 2 intrahepatic cholangiocarcinoma, 6 liver metastasis of colorectal cancer) with right-liver tumors underwent

conclusions90Y-SIRT represents a safe and efficacious strategy to convert initially unresectable patients into surgical candidates.

Indexed as

Disease control rateFuture liver remnantObjective response rateRight liver malignant tumorYttrium-90 selective internal radiation therapy

Identifiers

PMID40889027
PMCPMC12401783

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.